Geron (GERN)
(Delayed Data from NSDQ)
$4.46 USD
+0.02 (0.45%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $4.47 +0.01 (0.22%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
Geron Corporation [GERN]
Reports for Purchase
Showing records 201 - 220 ( 245 total )
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
2Q11 UPDATE - DIVERSIFIED PIPELINE REDUCES RISK - 2012 PIVOTAL YEAR
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
FIRST PATIENT IN SPINAL CORD TRIAL PASSES 180-DAY SAFETY MARK
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
FIRST PATIENT IN SPINAL CORD TRIAL PASSES 180-DAY SAFETY MARK
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Analyst Day Round 2 - Cell Therapy Programs Highlighted & Development Timelines Outlined
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Analyst Day Round 2 - Cell Therapy Programs Highlighted & Development Timelines Outlined
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Enrollment in Imetelstat Phase 2?s Proceeding Well
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
NEW MANAGEMENT TEAM - FOCUS ON COMMERCIALIZATION OF ASSETS
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
NEW MANAGEMENT TEAM - FOCUS ON COMMERCIALIZATION OF ASSETS
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
2010 RECAP & 2011 PREVIEW
Provider: RODMAN & RENSHAW, CO.